Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Sanjiv S Agarwala; Jurgen C Becker; Alexander M Eggermont; Keith T Flaherty; Claus Garbe; Alisa M Goldstein; Allan Halpern; Mohammed Kashani-Sabet; Axel Hauschild; John M Kirkwood; Sancy Leachman; Paul Lorigan; Martin McMahon; Jane Messina; Antoni Ribas; Wolfram E Samlowski; Dirk Schadendorf; Vernon K Sondak

doi:10.1111/j.1755-148X.2009.00602.x

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Pigment Cell Melanoma Res. 2009 Oct;22(5):532-43. doi: 10.1111/j.1755-148X.2009.00602.x. Epub 2009 Jun 29.

Authors

Sanjiv S Agarwala¹, Jurgen C Becker, Alexander M Eggermont, Keith T Flaherty, Claus Garbe, Alisa M Goldstein, Allan Halpern, Mohammed Kashani-Sabet, Axel Hauschild, John M Kirkwood, Sancy Leachman, Paul Lorigan, Martin McMahon, Jane Messina, Antoni Ribas, Wolfram E Samlowski, Dirk Schadendorf, Vernon K Sondak

Affiliation

¹ Oncology and Hematology, St. Luke's Cancer Center, Bethlehem, PA, USA. AgarwaS@slhn.org

PMID: 19659612
DOI: 10.1111/j.1755-148X.2009.00602.x

Abstract

This overview of the current state of melanoma research and treatment and directions for moving forward represents the consensus of discussions between expert panelists at the First and Second Global Workshops on Melanoma held in Fajardo, Peurto Rico on November 30-December 1, 2007 and Clearwater Beach, Florida on November 19-20, 2008.

MeSH terms

Antineoplastic Agents / therapeutic use
Apoptosis / physiology
Biomarkers / metabolism
Biomedical Research*
Clinical Trials as Topic
Congresses as Topic*
Consensus
Female
Humans
Immune System / physiology
Male
Melanoma* / drug therapy
Melanoma* / physiopathology
Melanoma* / prevention & control
Signal Transduction / physiology

Substances

Antineoplastic Agents
Biomarkers